Transaction DateRecipientSharesTypePriceValue
27th October 2020Craig B Reynolds10,000Exercise of derivative$23.04$230,400.00
27th October 2020Craig B Reynolds10,000Open or private sale$250.00$2,500,000.00
21st October 2020Donald J Spence2,719Grant/award etc.$0.00
21st October 2020Donald J Spence6,119Grant/award etc.$0.00
20th October 2020Gregoire Ramade2,000Exercise of derivative$3.78$7,560.00
20th October 2020Geoff Pardo233,333Open or private purchase$18.00$4,199,994.00
20th October 2020Geoff Pardo3,685,358Conversion of derivative$0.00
20th October 2020Gregoire Ramade2,000Open or private sale$30.62$61,240.00
14th October 2020James W Liken751Grant/award etc.$29.95$22,492.45
14th October 2020Anthony L. Arnerich396Grant/award etc.$29.95$11,860.20
Vapotherm logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.

Ticker: VAPO
Sector: Healthcare
Industry: Medical Devices
SEC Central Index Key (CIK): 1253176
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $148 M (0%)
Inventory, Net: $19 M (0%)
Assets, Current: $188 M (101%)
Property, Plant and Equipment, Net: $17 M (14%)
Other Assets, Noncurrent: $954 Th (13%)
Assets: $209 M (86%)
Accounts Payable, Current: $7 M (101%)
Accrued Liabilities, Current: $16 M (71%)
Liabilities, Current: $27 M (68%)
Other Liabilities, Noncurrent: $604 Th (247%)
Liabilities: $70 M (20%)
Common Stock, Value, Issued: $26 Th (23%)
Common Stock, Shares, Issued: $25 M (22%)
Additional Paid in Capital, Common Stock: $426 M (33%)
Retained Earnings (Accumulated Deficit): $287 M (8%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $31 Th (-29%)
Stockholders' Equity (Parent): $139 M (0%)
Liabilities and Equity: $209 M (86%)
Revenue: $35 M (-35%)
Gross Margin: $18 M (-34%)
Research and Development: $4 M (-46%)
Sales and Marketing: $15 M (-47%)
General and Administrative Expenses: $6 M (-48%)
Operating Income/Loss: $7 M (-65%)